PVI
PHAT icon

Pura Vida Investments’s Phathom Pharmaceuticals PHAT Stock Holding History

Pura Vida Investments’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-102,328
Closed -$864K – 240
2022
Q2 		$864K Hold
102,328
– – 0.05% 169
2022
Q1 		$1.39M Buy
102,328
+600
+0.6% +$9.69K 0.05% 175
2021
Q4 		$2M Buy
101,728
+69,153
+212% +$1.63M 0.07% 148
2021
Q3 		$1.05M Sell
32,575
-12,636
-28% -$420K 0.03% 218
2021
Q2 		$1.53M Sell
45,211
-18,561
-29% -$665K 0.05% 166
2021
Q1 		$2.4M Buy
63,772
+3,772
+6% +$158K 0.07% 152
2020
Q4 		$1.99M Buy
+60,000
New +$2.43M 0.07% 145

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pura Vida Investments's PHAT Position: Q3 2022 in Review

Pura Vida Investments sold out of Phathom Pharmaceuticals (PHAT) in Q3 2022, closing a stake of 102,328 shares — an estimated $864K sold.

Pura Vida Investments first reported a position in PHAT in Q4 2020 and held it in 7 quarters. The position peaked at $2.4M in Q1 2021. 94 funds tracked by Wall St. Rank hold PHAT as of Q3 2022.

  • Pura Vida Investments reported no remaining Phathom Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Pura Vida Investments sold 102,328 Phathom Pharmaceuticals shares in Q3 2022, an estimated $864K.
  • Pura Vida Investments first reported a position in Phathom Pharmaceuticals in Q4 2020 and held it in 7 quarters.
  • Pura Vida Investments's Phathom Pharmaceuticals position peaked at $2.4M in Q1 2021.
  • 94 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2022.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.